Flagship Pioneering Special Opportunities Fund Ii, L.p. - Net Worth and Insider Trading

Flagship Pioneering Special Opportunities Fund Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Special Opportunities Fund Ii, L.p. owns 3 companies in total, including Foghorn Therapeutics Inc (FHTX) , Sigilon Therapeutics Inc (SGTX) , and Omega Therapeutics Inc (OMGA) .

Click here to see the complete history of Flagship Pioneering Special Opportunities Fund Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Flagship Pioneering Special Opportunities Fund Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
FHTX Foghorn Therapeutics Inc 2020-10-22 10 percent owner
SGTX Sigilon Therapeutics Inc 2020-12-03 10 percent owner
OMGA Omega Therapeutics Inc 2021-07-29 10 percent owner

Flagship Pioneering Special Opportunities Fund Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Flagship Pioneering Special Opportunities Fund Ii, L.p. Ownership Network

Ownership Network List of Flagship Pioneering Special Opportunities Fund Ii, L.p.

No Data

Ownership Network Relation of Flagship Pioneering Special Opportunities Fund Ii, L.p.

Insider Network Chart

Flagship Pioneering Special Opportunities Fund Ii, L.p. Owned Company Details

What does Foghorn Therapeutics Inc do?

Who are the key executives at Foghorn Therapeutics Inc?

Flagship Pioneering Special Opportunities Fund Ii, L.p. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .

Foghorn Therapeutics Inc (FHTX) Insider Trades Summary

Over the past 18 months, Flagship Pioneering Special Opportunities Fund Ii, L.p. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .

In summary, during the past 3 months, insiders sold 30,672 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 30,672 shares. During the past 18 months, 352,969 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,969 shares.

Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Foghorn Therapeutics Inc Insider Transactions

No Available Data

Flagship Pioneering Special Opportunities Fund Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Flagship Pioneering Special Opportunities Fund Ii, L.p.. You might contact Flagship Pioneering Special Opportunities Fund Ii, L.p. via mailing address: 55 Cambridge Parkway, Cambridge Ma 02142.

Discussions on Flagship Pioneering Special Opportunities Fund Ii, L.p.

No discussions yet.